DNTH
Dianthus Therapeutics, Inc. · Healthcare
EVP, CFO & CBO Ryan Savitz sold $3.2M of Dianthus Therapeutics, Inc.
Sold$3,157,151
$101.03Price
31,249Shares
−100%Stake
What DNTH did after the filing
- The stock from Tue, Jul 14 open, $99.85
- +10.9%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Aug 26 close.
Traded Thu, Jul 9. Filed Mon, Jul 13, 5:00 PM ET, after the close. Returns use the Jul 14 open and the Aug 26 close. Not investment advice.